Jillian B. Thomsen, SVP & Chief Accounting Officer at NEKTAR THERAPEUTICS (NKTR), sold 2,713 shares at $17.97 ($49K) on 2019-11-18, disclosed to the SEC on 2019-11-20.
Seasonal sale ($49k) by SVP & Chief Accounting Officer — this insider has traded NKTR in November in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| Filing → |
| NKTR | SELL | 2022-08-17 | $10K | — | Filing → |
| NKTR | SELL | 2022-05-17 | $23K | — | Filing → |
| NKTR | SELL | 2022-02-18 | $26K | — | Filing → |